Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000896264-24-000222
Filing Date
2024-11-05
Accepted
2024-11-05 12:56:04
Documents
61
Period of Report
2024-09-28

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20240928.htm   iXBRL 10-Q 800192
2 THIRD AMENDMENT TO THE SECOND AMENDED AND RESTATED CREDIT AGREEMENT thirdamendmenttosecondamen.htm EX-10.23 127376
3 EX-31.1 usna-20240928xex311.htm EX-31.1 10017
4 EX-31.2 usna-20240928xex312.htm EX-31.2 9881
5 EX-32.1 usna-20240928xex321.htm EX-32.1 3494
6 EX-32.2 usna-20240928xex322.htm EX-32.2 3894
  Complete submission text file 0000896264-24-000222.txt   4298701

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20240928.xsd EX-101.SCH 26142
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT usna-20240928_cal.xml EX-101.CAL 44960
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT usna-20240928_def.xml EX-101.DEF 77441
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20240928_lab.xml EX-101.LAB 417357
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20240928_pre.xml EX-101.PRE 265354
63 EXTRACTED XBRL INSTANCE DOCUMENT usna-20240928_htm.xml XML 474927
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 241426608
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)